Preclinical evidence demonstrates neuropeptide Y's analgesic effects in chronic pain models, highlighting its importance for developing new treatments.
Key Points
NEUROPEPTIDE Y shows promise in treating chronic pain by acting on the Y1 receptor in neurons.
Research indicates that Y1 interneurons are crucial for the sensory and affective aspects of pain sensation.
Different agonists or antagonists targeting NPY receptors may provide tailored treatment for various pain conditions.
Innovative delivery methods, such as intranasal administration, are being explored to effectively use NPY in pain relief.